Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Loblaw

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 15, 2022
In Reply to Yamazaki et alHima Bindu Musunuru, Andrew Loblaw
The Canadian Journal of Urology|March 11, 2006
External beam irradiation for localized prostate cancer--the promise of hypofractionationD Andrew Loblaw, Patrick Cheung
World Journal of Urology|November 3, 2023
The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus?Wee Loon Ong, Andrew Loblaw
European Urology|October 10, 2024
Radiotherapy for Unfavorable-risk Prostate Cancer: Biologic Dose Escalation, Fewer Fractions, or Both?Wee Loon Ong, Andrew Loblaw
The Journal of Supportive Oncology|August 4, 2011
The optimal dose fractionation schema for malignant extradural spinal cord compressionD Andrew Loblaw, Gunita Mitera
The Journal of Urology|September 6, 2006
Modeling prostate specific antigen kinetics in patients on active surveillanceLiying Zhang, Andrew Loblaw, Laurence Klotz
Translational Andrology and Urology|July 28, 2018
Stereotactic ablative body radiotherapy in patients with prostate cancerAndrew Loblaw, Stanley Liu, Patrick Cheung
The Journal of Urology|May 19, 2010
Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristicsYonah Krakowsky, Andrew Loblaw, Laurence Klotz
BJU International|April 22, 2011
Dramatic increase in prostate cancer cases by 2021Harvey Quon, Andrew Loblaw, Robert Nam
Frontiers in Oncology|July 25, 2022
Stereotactic Body Radiotherapy: Hitting Harder, Faster, and Smarter in High-Risk Prostate CancerRohann J M Correa, Andrew Loblaw
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
International Journal of Radiation Oncology, Biology, Physics|April 15, 2022
In Reply to Yamazaki et alHima Bindu Musunuru, Andrew Loblaw
The Canadian Journal of Urology|March 11, 2006
External beam irradiation for localized prostate cancer--the promise of hypofractionationD Andrew Loblaw, Patrick Cheung
World Journal of Urology|November 3, 2023
The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer-Quo Vadimus?Wee Loon Ong, Andrew Loblaw
European Urology|October 10, 2024
Radiotherapy for Unfavorable-risk Prostate Cancer: Biologic Dose Escalation, Fewer Fractions, or Both?Wee Loon Ong, Andrew Loblaw
The Journal of Supportive Oncology|August 4, 2011
The optimal dose fractionation schema for malignant extradural spinal cord compressionD Andrew Loblaw, Gunita Mitera
The Journal of Urology|September 6, 2006
Modeling prostate specific antigen kinetics in patients on active surveillanceLiying Zhang, Andrew Loblaw, Laurence Klotz
Translational Andrology and Urology|July 28, 2018
Stereotactic ablative body radiotherapy in patients with prostate cancerAndrew Loblaw, Stanley Liu, Patrick Cheung
The Journal of Urology|May 19, 2010
Prostate cancer death of men treated with initial active surveillance: clinical and biochemical characteristicsYonah Krakowsky, Andrew Loblaw, Laurence Klotz
BJU International|April 22, 2011
Dramatic increase in prostate cancer cases by 2021Harvey Quon, Andrew Loblaw, Robert Nam
Frontiers in Oncology|July 25, 2022
Stereotactic Body Radiotherapy: Hitting Harder, Faster, and Smarter in High-Risk Prostate CancerRohann J M Correa, Andrew Loblaw
Pageof 28